×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
CONDITION VS INDICATION / PIP SCOPE
Session Chair(s)
Klaus Rose, MD, MS
Chief Executive Officer
klausrose Consulting, Switzerland
Speaker(s)
Defining the Condition(s) in a Paediatric Investigation Plan/Waiver – EMA perspective
Ralph Bax, MD, PhD
European Medicines Agency, Netherlands
Head of the Paediatric Medicines Office
Defining the Condition(s) in a Paediatric Investigation Plan/Waiver – Industry perspective
Anne De Bock
AstraZeneca, Belgium
Sr Regional Director
Have an account?